Abstract

The immune-suppressive effects of omega-3 (n-3) polyunsaturated fatty acids (PUFAs) on T cells have been observed via multiple in vitro and in vivo models. However, the precise mechanism that causes these effects is still undefined. In this study, we investigated whether n-3 PUFAs regulated T cell receptor (TCR) and peptide-major histocompatibility complex (pMHC) interactions. The expansion of anti-viral CD8+ T cells that endogenously synthesize n-3 PUFAs (FAT-1) dramatically decreased upon lymphocytic choriomeningitis virus (LCMV) infection in vivo. This decrease was not caused by the considerable reduction of TCR expression or the impaired chemotactic activity of T cells. Interestingly, a highly inclined and laminated optical sheet (HILO) microscopic analysis revealed that the TCR motility was notably reduced on the surface of the FAT-1 CD8+ T cells compared to the wild type (WT) CD8+ T cells. Importantly, the adhesion strength of the FAT-1 CD8+ T cells to the peptide-MHC was significantly lower than that of the WT CD8+T cells. Consistent with this result, treatment with docosahexaenoic acid (DHA), one type of n-3 PUFA, significantly decreased CD8+ T cell adhesion to the pMHC. Collectively, our results reveal a novel mechanism through which n-3 PUFAs decrease TCR-pMHC interactions by modulating TCR mobility on CD8+ T cell surfaces.

Highlights

  • Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are immunological modulators that can prevent unwanted hyper-immune responses [1,2]

  • We investigated the potential role of n-3 PUFAs in regulating the T cell receptor (TCR)-peptide-major histocompatibility complex (pMHC)

  • Since TCR-pMHC interaction is prerequisite for the activation of T cells, we investigated whether endogenous n-3 PUFAs affect the TCR mobility of CD8+ T cells

Read more

Summary

Introduction

Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are immunological modulators that can prevent unwanted hyper-immune responses [1,2]. Their anti-inflammatory effects have been reported for various autoimmune diseases such as asthma, inflammatory bowel disease, and rheumatoid arthritis [3,4,5,6,7,8]. Excessive or undesired immune responses caused by bacterial and viral infections can be suppressed with a n-3 PUFA treatment [9,10,11,12,13,14]. The activation of CD4+ and CD8+ T cells was blunted after treatment with the n-3 PUFAs [3,13,15,16,17,18,19,20].

Objectives
Methods
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call